Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Aldoss

Showing results (21-30 of 233) with videos related to

Pageof 24
Sort By:
JAMA Oncology|May 1, 2025
Management of Adult Acute Lymphoblastic Leukemia: A ReviewHagop Kantarjian, Ibrahim Aldoss, Elias Jabbour
Immunology Letters|February 28, 2016
Monoclonal antibodies and immune therapies for adult precursor B-acute lymphoblastic leukemiaSwati Sikaria, Ibrahim Aldoss, Mojtaba Akhtari
Clinical Lymphoma, Myeloma & Leukemia|September 16, 2022
SOHO State of the Art Updates and Next Questions | Asparaginase-Understanding and Overcoming Toxicities in Adults with ALLIbrahim Aldoss, Hoda Pourhassan, Dan Douer
Leukemia & Lymphoma|August 5, 2025
Extramedullary sites of disease in B-cell acute lymphoblastic leukemia: incidence, biology, and treatmentVaibhav Agrawal, Ibrahim Aldoss, Vinod Pullarkat
Best Practice & Research. Clinical Haematology|December 6, 2021
Will immunotherapy lead to a breakthrough in the treatment of older adults with ALL?Ibrahim Aldoss, Anjali Advani, Vinod Pullarkat
Current Treatment Options in Oncology|June 7, 2021
Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete RemissionShukaib Arslan, Vinod Pullarkat, Ibrahim Aldoss
Blood Reviews|June 26, 2019
Therapy-related acute lymphoblastic leukemia: Where do we stand with regards to its definition and characterization?Ibrahim Aldoss, Dan Douer, Vinod Pullarkat
Current Hematologic Malignancy Reports|June 12, 2024
Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen SelectionHoda Pourhassan, Lindsey Murphy, Ibrahim Aldoss
Therapeutic Advances in Hematology|February 25, 2021
Venetoclax-containing regimens in acute myeloid leukemiaIbrahim Aldoss, Vinod Pullarkat, Anthony S Stein
Journal of Oncology Practice|February 15, 2019
Acute Lymphoblastic Leukemia in the Older AdultIbrahim Aldoss, Stephen J Forman, Vinod Pullarkat
Pageof 24

Showing results (21-30 of 233) with videos related to

Sort By:
Pageof 24
JAMA Oncology|May 1, 2025
Management of Adult Acute Lymphoblastic Leukemia: A ReviewHagop Kantarjian, Ibrahim Aldoss, Elias Jabbour
Immunology Letters|February 28, 2016
Monoclonal antibodies and immune therapies for adult precursor B-acute lymphoblastic leukemiaSwati Sikaria, Ibrahim Aldoss, Mojtaba Akhtari
Clinical Lymphoma, Myeloma & Leukemia|September 16, 2022
SOHO State of the Art Updates and Next Questions | Asparaginase-Understanding and Overcoming Toxicities in Adults with ALLIbrahim Aldoss, Hoda Pourhassan, Dan Douer
Leukemia & Lymphoma|August 5, 2025
Extramedullary sites of disease in B-cell acute lymphoblastic leukemia: incidence, biology, and treatmentVaibhav Agrawal, Ibrahim Aldoss, Vinod Pullarkat
Best Practice & Research. Clinical Haematology|December 6, 2021
Will immunotherapy lead to a breakthrough in the treatment of older adults with ALL?Ibrahim Aldoss, Anjali Advani, Vinod Pullarkat
Current Treatment Options in Oncology|June 7, 2021
Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete RemissionShukaib Arslan, Vinod Pullarkat, Ibrahim Aldoss
Blood Reviews|June 26, 2019
Therapy-related acute lymphoblastic leukemia: Where do we stand with regards to its definition and characterization?Ibrahim Aldoss, Dan Douer, Vinod Pullarkat
Current Hematologic Malignancy Reports|June 12, 2024
Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen SelectionHoda Pourhassan, Lindsey Murphy, Ibrahim Aldoss
Therapeutic Advances in Hematology|February 25, 2021
Venetoclax-containing regimens in acute myeloid leukemiaIbrahim Aldoss, Vinod Pullarkat, Anthony S Stein
Journal of Oncology Practice|February 15, 2019
Acute Lymphoblastic Leukemia in the Older AdultIbrahim Aldoss, Stephen J Forman, Vinod Pullarkat
Pageof 24